Neuro-Oncology Reviews
Volume
26 Number 20
20 September 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 20, 20 September
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Medulloblastoma and Other
Central
Nervous System Embryonal Tumors Treatment (PDQ®): Health
Professional
Version.
PDQ
Cancer Inf Summ.
2024 Sep 11. NCBI
Bookshelf ID:
NBK65981.
PMID:
26389418.
Review.
ˍ
Baek C, Laurenge A, Touat M.
Advances
in the treatment of IDH-mutant gliomas.
Curr
Opin Neurol. 2024 Sep 12. doi:
10.1097/WCO.0000000000001316. PMID:
39253756. Review˰ ˍ
Dai ZY, Jiang Y, Wang FQ, Wang Y.
Primary
pulmonary meningioma: A case report and review of the literature.
Asian
J Surg. 2024 Sep 12:S1015-9584(24)01992-4. doi:
10.1016/j.asjsur.2024.09.007. PMID:
39271347. Case report; Review. ˍ
Lazarev S, Sindhu KK.
Vorasidenib: a
new hope or a false promise for patients with low-grade glioma?
Nat
Rev Clin Oncol. 2024 Sep 12. doi:
10.1038/s41571-024-00944-5. PMID:
39266767. Perspective˰
ˍ
Fukushima CM, de Groot J.
Updates for
newly diagnosed and recurrent glioblastoma: a review of recent
clinical trials.
Curr
Opin Neurol. 2024 Sep 13. doi:
10.1097/WCO.0000000000001320. PMID:
39258745. Review. ˍ
Gal O, Mehta MP, Kotecha R.
Radiotherapeutic
advances in the management of
glioblastoma.
J
Neurooncol. 2024 Sep 13. doi:
10.1007/s11060-024-04824-x. PMID:
39269554. Review˰ ˍ
Chellapandian H, Jeyachandran S.
Letter
to Editor, "The effects of dabrafenib
and/or trametinib treatment in Braf
V600mutant glioma: a systematic review and
metaanalysis".
Neurosurg
Rev. 2024 Sep 14;47(1):613. doi:
10.1007/s10143-024-02858-3. PMID:
39271502. Review; Meta-analysis˰
ˍ
Palavani LB, Verly G, Borges P, Neto L, Almeida M, Leite M,
Oliveira LB, Batista S, Bertani R, Polverini AD, de Macedo Filho
L, Paiva W.
Beyond surgical
resection: evaluating stereotactic
brachytherapy iodine-125 for low-grade
gliomas: a systematic review and
meta-analysis.
Neurosurg
Rev. 2024 Sep 14;47(1):617. doi:
10.1007/s10143-024-02839-6. PMID:
39276262. Review; Meta-analysis˰
ˍ
Almasi F, Nemati M, Aminianfar A.
Dietary
Recommendations for Glioma: A Mini-Review.
Curr
Nutr Rep. 2024 Sep 18. doi:
10.1007/s13668-024-00577-1. PMID:
39292335. Review˰
ˍ
Adegboyega G, Momin S, Gillespie CS, Jeelani NUO, Sudhakar S,
Mankad K, Tisdall MM, Aquilina K, Toescu SM.
Intraoperative
MRI in pediatric epilepsy and neuro-oncology: a systematic review
and meta-analysis.
J
Neurosurg Pediatr. 2024 Sep 20:1-14. doi:
10.3171/2024.6.PEDS2414. PMID:
39303299. Review; Meta-analysis˰
ˍ
Nakhate V, Lasica AB, Wen PY.
The Role
of Mutant IDH Inhibitors in the
Treatment of Glioma.
Curr
Neurol Neurosci Rep. 2024 Sep 20. doi:
10.1007/s11910-024-01378-3. PMID:
39302605. Review˰
ˍ
Arvaniti CK, Karagianni MD, Papageorgakopoulou MA, Brotis AG,
Tasiou A, Fountas KN.
The role of
lobectomy in glioblastoma management: A systematic review and
meta-analysis.
Brain
Spine. 2024 Apr 23;4:102823. doi:
10.1016/j.bas.2024.102823. PMID:
39285857. Review. ˍ
Pace A.
Socioeconomic driven
disparities in neuro-oncology.
Neurooncol
Pract. 2024 Aug 7;11(5):511-512. doi:
10.1093/nop/npae071. PMID:
39279770. Editorial˰ ˍ
Internò V, Melaccio A, Vitale P, Spedaliere R, Buonfantino
M, Messina R, Lippolis AL, Signorelli F, Addeo R, Giuliani F.
Therapeutic inhibition of isocitrate
dehydrogenase mutations in glioma and cholangiocarcinoma: new
insights and promises-a narrative review.
Chin
Clin Oncol. 2024 Aug 21:cco-24-17. doi:
10.21037/cco-24-17. PMID:
39260430. Review. ˍ
Rahman MA, Ali MM.
Recent Treatment
Strategies and Molecular Pathways in Resistance Mechanisms of
Antiangiogenic Therapies in Glioblastoma.
Cancers
(Basel). 2024 Aug 27;16(17):2975. doi:
10.3390/cancers16172975. PMID:
39272834. Review. ˍ
Ghazi B, Harmak Z, Rghioui M, Kone AS, El Ghanmi A, Badou A.
Decoding the secret of extracellular
vesicles in the immune tumor microenvironment of the glioblastoma:
on the border of kingdoms.
Front
Immunol. 2024 Aug 29;15:1423232. doi:
10.3389/fimmu.2024.1423232. PMID:
39267734. Review. ˍ
Huo X, Li H, Xing Y, Liu W, Chen P, Du F, Song L, Yu Z, Cao X,
Tian J.
Two decades of progress in
glioma methylation research: the rise of temozolomide resistance
and immunotherapy insights.
Front
Neurosci. 2024 Sep 2;18:1440756. doi:
10.3389/fnins.2024.1440756. PMID:
39286478. Bibliometric analysis. ˍ
.
Lotsch C, Warta R, Herold-Mende C.
The
Molecular and Immunological Landscape
of Meningiomas.
Int
J Mol Sci. 2024 Sep 5;25(17):9631. doi:
10.3390/ijms25179631. PMID:
39273576. Review. ˍ
*Yoel A, Adjumain S, Liang Y, Daniel P, Firestein R, Tsui V.
Emerging and Biological Concepts in
Pediatric High-Grade Gliomas.
Cells.
2024 Sep 5;13(17):1492. doi:
10.3390/cells13171492. PMID:
39273062. Review. ˍ
Keane L, Cryan JF, Gleeson JP.
Exploiting
the gut microbiome for brain tumour
treatment.
Trends
Mol Med. 2024 Sep 10:S1471-4914(24)00222-3. doi:
10.1016/j.molmed.2024.08.008. PMID:
39256110. Review. ˍ